The Northstar AI Results Explorer can be incorporated directly into existing clinical workflows. Within the platform, radiologists can not only view AI-produced images and reports, but also assess individual measurements, markings and other findings generated by the technology, examining the AI’s decision-making process to determine and fine-tune the data’s accuracy and thus accept or reject the algorithm’s findings.
The FDA gave the platform a “first-of-kind” determination, labeling it a Class I medical device and therefore granting it full commercial availability.
Editor’s note: This article was updated June 25 at 9:00 a.m. to clarify the FDA’s determination.
More articles about AI:
Updated White House AI policy prioritizes public-private collaboration
Philips updates AI-enabled cardiac ultrasound platform to make it faster, easier to use
AI-guided robotic device replaces endoscopy in diagnosing colon cancer
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
